Category:Graft versus host disease medications
Jump to navigation
Jump to search
Medications used to treat the symptoms of graft versus host disease (GVHD). Ibrutinib (Imbruvica) is the only currently FDA-approved therapy for the treatment of chronic GVHD.
Pages in category "Graft versus host disease medications"
The following 9 pages are in this category, out of 9 total.